Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris P Miller

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Current Pharmaceutical Design|August 13, 2002
SERMs: evolutionary chemistry, revolutionary biologyChris P Miller
Chirality|January 18, 2008
A consideration of the patentability of enantiomers in the pharmaceutical industry in the United StatesChris P Miller, John W Ullrich
Anticancer Research|April 22, 2011
Quantitative comparison of erythropoietin receptor levels in the epithelial versus endothelial fractions of primary breast tumorsChris P Miller, Nicole Urban, C Anthony Blau
Bioorganic & Medicinal Chemistry Letters|June 26, 2003
Constrained phytoestrogens and analogues as ERbeta selective ligandsChris P Miller, Michael D Collini, Heather A Harris
Blood|January 25, 2002
Erythropoietin receptor-dependent erythroid colony-forming unit development: capacities of Y343 and phosphotyrosine-null receptor formsChris P Miller, Destin W Heilman, Don M Wojchowski
Translational Oncology|June 22, 2010
Limitations of a murine transgenic breast cancer model for studies of erythropoietin-induced tumor progressionChris P Miller, Karine Valliant-Saunders, Carl Anthony Blau
Neoplasia (New York, N.Y.)|May 11, 2018
A 3D Human Renal Cell Carcinoma-on-a-Chip for the Study of Tumor AngiogenesisChris P Miller, Connor Tsuchida, Ying Zheng, et al.
Human Vaccines & Immunotherapeutics|March 5, 2021
Current status of antigen-specific T-cell immunotherapy for advanced renal-cell carcinomaYuexin Xu, Chris P Miller, Edus H Warren, et al.
Experimental Hematology|June 26, 2007
MicroRNA expression dynamics during murine and human erythroid differentiationMei Zhan, Chris P Miller, Thalia Papayannopoulou, et al.
Frontiers in Cell and Developmental Biology|May 10, 2024
Signaling crosstalk between tumor endothelial cells and immune cells in the microenvironment of solid tumorsYuexin Xu, Chris P Miller, Scott S Tykodi, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Current Pharmaceutical Design|August 13, 2002
SERMs: evolutionary chemistry, revolutionary biologyChris P Miller
Chirality|January 18, 2008
A consideration of the patentability of enantiomers in the pharmaceutical industry in the United StatesChris P Miller, John W Ullrich
Anticancer Research|April 22, 2011
Quantitative comparison of erythropoietin receptor levels in the epithelial versus endothelial fractions of primary breast tumorsChris P Miller, Nicole Urban, C Anthony Blau
Bioorganic & Medicinal Chemistry Letters|June 26, 2003
Constrained phytoestrogens and analogues as ERbeta selective ligandsChris P Miller, Michael D Collini, Heather A Harris
Blood|January 25, 2002
Erythropoietin receptor-dependent erythroid colony-forming unit development: capacities of Y343 and phosphotyrosine-null receptor formsChris P Miller, Destin W Heilman, Don M Wojchowski
Translational Oncology|June 22, 2010
Limitations of a murine transgenic breast cancer model for studies of erythropoietin-induced tumor progressionChris P Miller, Karine Valliant-Saunders, Carl Anthony Blau
Neoplasia (New York, N.Y.)|May 11, 2018
A 3D Human Renal Cell Carcinoma-on-a-Chip for the Study of Tumor AngiogenesisChris P Miller, Connor Tsuchida, Ying Zheng, et al.
Human Vaccines & Immunotherapeutics|March 5, 2021
Current status of antigen-specific T-cell immunotherapy for advanced renal-cell carcinomaYuexin Xu, Chris P Miller, Edus H Warren, et al.
Experimental Hematology|June 26, 2007
MicroRNA expression dynamics during murine and human erythroid differentiationMei Zhan, Chris P Miller, Thalia Papayannopoulou, et al.
Frontiers in Cell and Developmental Biology|May 10, 2024
Signaling crosstalk between tumor endothelial cells and immune cells in the microenvironment of solid tumorsYuexin Xu, Chris P Miller, Scott S Tykodi, et al.
Pageof 4